19 November 2026

UK company announcements filtered and explained for private investors.

CT Automotive Group PLC (CTA) · 2026-11-19

Trading Update

CT Automotive expects FY26 revenue of $121.0m, slightly below market expectations of $126.8m, and has cut FY26 Adjusted PBT to approximately $0.3m from the $4.9m–$9.4m range given on 16 September 2026; for FY27, it expects revenue slightly above revised FY26 revenue and operational profitability margin to substantially recover, although European demand is subject to greater uncertainty and may weaken amid wider macroeconomic headwinds, cash constraints are assumed to continue into Q1 2027, and forecasts remain subject to FX movements. The profit measure excludes severance costs, hyperinflation and non-cash translational FX.

Iomart Group PLC (IOM) · 2026-11-19

H1’27 Trading Update and FY’27 Outlook

Iomart expects H1 FY27 revenue of about £68.9m and adjusted EBITDA of about £8.9m, down from £77.7m and £12.5m in H1 FY26, while FY27 revenue and adjusted EBITDA are expected to be about 4% and 16% below Company-compiled consensus. Net debt rose to about £117.2m at 30 September 2026 from £108.6m at 31 March 2026 as weaker revenue reduced cash generation.

McBride PLC (MCB) · 2026-11-19

AGM Trading Update

McBride’s Q1 like-for-like revenue rose about 4% and volumes about 2%, excluding Eurotab, but the Board expects FY27 adjusted EBITA to be 20% to 25% below the current Group-compiled analyst consensus of £62.9m. Margin recovery towards previous levels is now expected in Q4 FY27 rather than Q2, after operational issues that hurt service levels were materially resolved.

JD Sports Fashion PLC (JD.) · 2026-11-19

Q3 2026/27 TRADING STATEMENT

JD Sports Fashion narrowed FY27 profit before tax and adjusting items guidance to £700m-£750m from £700m-£800m, despite improved Q3 sales trends. Free cash flow guidance remains £460m-£520m.

Johnson Matthey PLC (JMAT) · 2026-11-19

Johnson Matthey half year results

Johnson Matthey’s unaudited half-year underlying operating profit rose 13% excluding Cormetech and the benefit from higher PGM prices, or 32% to £187 million including them, but free cash flow was a £98 million outflow versus a £4 million inflow a year earlier. It upgraded 2026/27 group underlying operating-profit growth to high-single-digit percentage growth, at constant precious-metal prices and currency and excluding Catalyst Technologies and Cormetech. The interim accounts were reviewed by the auditors.

Halma PLC (HLMA) · 2026-11-19

Half Year Results

Halma’s unaudited, PwC-reviewed half-year revenue reached a record £1,433.2m, up 15.8%, while adjusted EBIT rose 22.5% to £345.4m; it still expects FY2026/27 low double-digit organic constant-currency revenue growth and a 23.5%-24.0% adjusted EBIT margin despite elevated economic and geopolitical uncertainty. Acquisition spending lifted net debt to £966.1m from £769.1m at 31 March, though leverage remained within its stated range.

Investec PLC (INVP) · 2026-11-19

FY27 Interim Results 30SEP26

Investec reported higher first-half revenue, adjusted operating profit and EPS, but costs rose faster than income; for FY2027 it expects ROE of 13.0% to 14.0%, ROTE of 14.8% to 15.8%, a 52.0% to 54.0% cost-to-income ratio and a 25 to 45 basis-point credit-loss ratio. Adjusted operating profit rose 5.6% to £494.5m and adjusted EPS rose 7.4% to 43.5p, while the cost-to-income ratio increased to 53.3% from 51.9%.

Manolete Partners PLC (MANO) · 2026-11-19

Half-year results

Manolete Partners reported record unaudited H1 realised revenue of £17.4m, up 23%, and adjusted realised PBT of £1.6m, up 66%; the Board is confident of achieving FY27 market consensus of £30.6m realised revenue and £1.5m adjusted realised PBT. Cash receipts fell to £12.8m and case investment drove £2.0m net cash outflow, lifting half-year net debt to £13.6m before it fell to £11.2m after period-end receipts.

Mitie Group PLC (MTO) · 2026-11-19

H1 FY27 Results

Mitie Group reported higher H1 FY27 underlying profit and £104.6m free cash inflow, including £43.1m from a new non-recourse receivables purchasing arrangement, and expects to meet its FY25-FY27 strategic-plan targets; statutory operating profit and EPS fell as Other items increased. Revenue rose to £2,896.5m from £2,677.2m, while operating profit before Other items increased to £123.5m from £108.8m.

Eagle Eye PLC (EYE) · 2026-11-19

AGM trading statement

Eagle Eye expects FY27 results to be in line with market expectations, with double-digit revenue and adjusted EBITDA growth, after securing four new contracts and a significant renewal.

Knights Group Holdings PLC (KGH) · 2026-11-19

Trading Update

Knights Group Holdings expects H1 FY27 underlying PBT of £17.4m, up 6.1%, and says this performance underpins confidence in delivering full-year profits in line with expectations, though net debt is expected to rise to £79.4m at 31 October 2026.

Grainger PLC (GRI) · 2026-11-19

Preliminary Full Year Financial Results

Grainger met FY26 pre-tax EPRA earnings guidance with £60.2m, but retained a back-end-weighted £72m FY29 target that is expected to absorb substantial higher interest-rate headwinds. Valuation movements drove a £41.8m IFRS pre-tax loss and reduced EPRA NTA to 281p per share from 298p.

Great Portland Estates plc (GPE) · 2026-11-19

Another strong half-year performance

Great Portland Estates reported unaudited diluted EPRA EPS of 5.6p for the six months ended 30 September 2026, in line with GPE guidance, and maintained portfolio rental-value-growth guidance of 4.0% to 7.0% for the year ending 31 March 2027. Its November sale of 2 Aldermanbury Square for £368.7 million net reduced pro forma LTV to 21.9%.

MHA PLC (MHA) · 2026-11-19

Half Year Results

MHA’s unaudited H1 27 revenue rose 11% to £134.6m, and FY27 trading is in line with market expectations, but net cash from operating activities fell to £16.663m from £36.054m. Net cash fell to £18.0m from £25.4m, although directors said liquidity is sufficient for at least 12 months.

Concurrent Technologies PLC (CNC) · 2026-11-19

Result of Placing and Subscription

Concurrent Technologies has raised approximately £35 million gross through a conditional placing and director subscriptions at 250 pence per share, 6.5% below the prior closing price. The new shares will enlarge the share base if Fundraising Admission completes.

Alternative Income REIT PLC (AIRE) · 2026-11-19

Compulsory Acquisition of Remaining AIRE Shares

Alternative Income REIT is nearing full takeover by Glenstone, which holds or has valid acceptances for 93.15% of its shares and can begin compulsory acquisition of the remainder. Remaining holders can accept 70p cash per share while the offer stays open, subject to the stated dividend terms.

BTG Consulting plc (BTG) · 2026-11-19

Half-year trading update

BTG Consulting grew first-half revenue by about 11% and adjusted profit before tax by about 15%, and is confident of meeting FY27 adjusted PBT market expectations of £26.5m–£26.9m. Net debt rose to £10.2m at 31 October 2026, reflecting acquisition payments and dividends.

Sage Group (The) PLC (SGE) · 2026-11-19

Results for the year ended 30 September 2026

Sage delivered audited FY26 underlying revenue growth of 11% to £2,783m and underlying operating profit growth of 13% to £681m; for FY27, management expects organic total revenue growth of around 10% but estimates an approximately £100m workforce restructuring charge, expected to be excluded from underlying results and subject to employee consultation. It also expects underlying operating margins to continue trending upwards.

Nationwide Building Society (NBS) · 2026-11-19

Interim Results September 2026

Nationwide Building Society reported reviewed but unaudited H1 2026/27 underlying profit before tax up 23% to £1.202bn, though impairment charges rose and operating cash flow swung to a £740m outflow. Statutory profit before tax rose to £673m from £486m after the Fairer Share payment.

Mountview Estates PLC (MTVW) · 2026-11-19

UNAUDITED INTERIM RESULTS - HY to 30 SEPT. 2026

Mountview Estates reported unaudited first-half revenue of £35.0m, profit before tax of £14.1m and EPS of 270.8p for the six months to 30 September 2026, all down year on year. The interim dividend was held at 250p per share, while unaudited bank overdraft and short-term loans fell from £39.0m at 31 March 2026 to nil at 30 September 2026.

Marks Electrical Group PLC (MRK) · 2026-11-19

Results for the six months ended 30 September 2026

Marks Electrical’s unaudited H1-27 statutory profit after tax was £0.753m, against a £0.464m loss, while management remains confident in revised FY27 market expectations following September’s upgrade to adjusted EBITDA of at least £3.75m; underlying free-cash outflow was £5.230m and period-end net debt was £0.8m. Unaudited H1-27 revenue fell 1.9% year on year to £52.0m.

The Smarter Web Company PLC (SWC) · 2026-11-19

MORE Preferred Shares Buyback

The Smarter Web Company bought back 3,265 MORE Preferred Shares for £253,925 at £77.50 each, about 13.89% below MORE’s original £90 offer price. It partly used about £0.2m from its Coinbase credit facility to fund the purchase, with drawings of about £19.2m afterwards.

Emmerson PLC (EML) · 2026-11-19

Capital Access Window

Emmerson PLC plans a potential equity fundraising through an AIM Rule 40 Capital Access Window, with trading set to be temporarily suspended from 7.30am GMT on 19 November 2026 until the fundraise concludes. Terms and conditions have not yet been announced.

Frasers Group PLC (FRAS) · 2026-11-19

Director/PDMR Shareholding

Frasers Group PLC disclosed that MASH Holdings, linked to PDMR Michael Ashley, sold 150,000 shares for £1.425m under a previously announced directed trading programme.

Kromek Group PLC (KMK) · 2026-11-19

Kromek receives £2.5m order from UK MOD

Kromek Group has received a £2.5m UK Ministry of Defence order for its D5 RIID wearable nuclear radiation detectors, to be delivered in the financial year ending 30 April 2027.

Scancell Holdings PLC (SCLP) · 2026-11-19

Scancell Provides Corporate and Clinical Update

Scancell Holdings gained FDA RMAT designation for investigational melanoma therapy inzitagene plasmivec, but expects its global Phase 3 trial to start with a first patient in December 2026 and says NASDAQ transaction completion would finance it. The proposed Neuphoria combination remains subject to shareholder approval, financing and other closing conditions.

Greatland Resources Ltd (GGP) · 2026-11-19

2026 AGM Chairman’s Address & Presentation

Greatland Resources has moved Havieron into construction after completing its feasibility study, securing primary environmental approvals and making a Final Investment Decision. The project will use Telfer’s existing processing plant, while Greatland reported a $1.29 billion cash balance at 30 June.

Costain Group PLC (COST) · 2026-11-19

Capital Markets Event

Costain says FY26 trading remains in line with market expectations and targets approximately 10% revenue CAGR and more than 10% adjusted operating-profit CAGR from an FY26 base in the medium term. It will launch a new £25m on-market share buyback in January 2027, with completion planned by the end of 2027.

Ilika PLC (IKA) · 2026-11-19

Trading Update & Notice of Half-Year Results

Ilika expects revenue of £0.4m and an EBITDA loss excluding share-based payments of £3.4m for the six months to 31 October 2026, versus £0.6m and a £3.2m loss in H1 2025/6; the revenue reduction reflects lower grant income after PRIMED completed, although Period cash expenditure was in line with Board expectations and the June 2026 fundraising investment programme. Stereax M300 batteries are in product validation at Cirtec, but broader release remains dependent on customer validation and a regulatory device-approval process that Cirtec says could take 3-5 years.

Cora Gold Ltd (CORA) · 2026-11-19

Drill Results at Zones A & C Confirm Extensions

Cora Gold’s drilling at Sanankoro confirmed mineralisation continuity and extensions, supporting potential resource growth but not yet a confirmed upgrade. Zone C mineralisation remains open at depth over about 250m of strike, while future pit optimisation could improve project economics, according to Cora.

80 Mile PLC (80M) · 2026-11-19

Initial Loan drawdown & Award of 2026 EBT shares

80 Mile received an initial £800,000 drawdown under its unsecured £3 million convertible loan facility with Greenland Energy, strengthening its funding access. It also conditionally reallocated 147,000,000 existing 2026 EBT shares, with vesting tied to market-capitalisation targets, service and completion of the proposed Greenland combination.

Angus Energy PLC (ANGS) · 2026-11-19

Saltfleetby Production and Brockham Update

Angus Energy said Saltfleetby production was about 7% below forecast over the past month after booster-compressor trips, but the instrumentation fault has been resolved and output is now stable and in line with the Company’s expectations.

Alkemy Capital Investments PLC (ALK) · 2026-11-19

Glencore increases to 100% TVL Offtake

Alkemy Capital Investments has expanded Glencore’s binding offtake ceiling to cover up to 25,000 tonnes a year, matching TVL’s planned Train 1 capacity, but value depends on future refinery production and market-based pricing.

Avacta Group PLC (AVCT) · 2026-11-19

AVA6207 Overcomes TOP1i Resistance

Avacta Group said preclinical AVA6207 data showed reversal of TOP1 inhibitor resistance, but the programme is not yet in clinical studies. IND-enabling studies are expected to begin in Q4 2026.

Gelion PLC (GELN) · 2026-11-19

Appointment of Worley for early phase engineering

Gelion PLC has appointed Worley Consulting for an expected 16-week pre-FEED programme for its NES™ pilot plant, with the work largely grant-funded and the balance budgeted. Gelion continues to explore non-dilutive funding opportunities to support pilot-plant construction.

Hutchmed (China) Ltd (HCM) · 2026-11-19

HUTCHMED Highlights HMPL-A830 Pre-Clinical Data

Hutchmed (China) presented preclinical HMPL-A830 data showing activity in tumour cell lines and mouse models, while Phase Ia is evaluating the drug in advanced solid tumours. The candidate remains early stage, and its therapeutic potential, safety and efficacy are uncertain.

Cobra Resources PLC (COBR) · 2026-11-19

Non-Dilutive Government Co-Funding Award

Cobra Resources has secured up to A$500,000 of non-dilutive South Australian government co-funding for planned exploration at Wudinna and Manna Hill, extending its exploration budget without issuing shares. The award comprises up to A$300,000 for Wudinna and up to A$200,000 for Manna Hill, but the programmes are intended tests rather than exploration results.

Ixico PLC (IXI) · 2026-11-19

IXI Platform & Collaborations Update

Ixico released an upgraded IXI™ brain-imaging platform and agreed collaborations with Neuropacs and ZRO Imaging, adding Parkinson’s disease and PET-imaging tools. The company says the more scalable platform could improve iCRO-service efficiency and create licensing and partnership revenue opportunities, but no financial benefit or contract value was disclosed.

GSK PLC (GSK) · 2026-11-19

Velzatinib obtains ODD in Japan for GIST treatment

GSK has received Japanese Orphan Drug Designation for velzatinib in gastrointestinal stromal tumour, alongside phase III trials in advanced disease. Second-line trial enrolment is tracking ahead of schedule, but GSK expects trial data in the second half of 2027.

Norcros PLC (NXR) · 2026-11-19

Appointment of Chief Financial Officer

Norcros has appointed Rohan Cummings as Chief Financial Officer and Executive Director from 1 January 2027.

Pri0R1Ty Intelligence Group PLC (PR1) · 2026-11-19

Reseller Agreement & Launch of Brand Sonar

Pri0r1ty has signed a non-exclusive Cookiebot reseller agreement, creating a recurring subscription-revenue route through a live automated sales funnel that generated revenue immediately. It receives 40% of fees for the first three years of subscriptions it manages and supports, then 20% thereafter.

Quantum Base Holdings PLC (QUBE) · 2026-11-19

Partnership with Customer #3

Quantum Base Holdings signed a non-exclusive agreement worth £250,000 over two and a half years, including minimum annual recurring revenue of £100,000, with its third global commercial customer. The first contract to include browser-based Q-ID authentication comes while the feature remains in final beta testing.

Mantle Resilience PLC (MNTL) · 2026-11-19

Business Update

Mantle Resilience’s 48.35%-owned Recyclus subsidiary has settled its HMRC obligations after support from existing clients, leading HMRC to withdraw its winding-up petition. The proposed D3IP acquisition remains conditional, with its completion deadline extended to 14 December 2026.

Forgent PLC (FORG) · 2026-11-19

Encouraging gold interval near Cathedral discovery

Forgent identified historical drilling at Cathedral, including 5m at 2.07g/t gold from 35m in EFAC2007, which management says raises the possibility of broader mineralisation. It is revising the programme to test this prospect, but follow-up drilling is still needed.

Tracsis PLC (TRCS) · 2026-11-19

Final Results

Tracsis’s FY26 continuing-operations adjusted EBITDA rose to £11.3m from £10.6m, and the Board expects FY27 adjusted EBITDA of at least £15.5m, in line with market expectations, but statutory continuing-operations loss before tax was £1.0m and free cash flow, including continuing and discontinued operations, fell to £3.0m from £7.7m. It completed the £48.0m enterprise-value acquisition of Mistral Data after year end, paying £48.886m in cash and drawing £38.7m under its extended £40m revolving credit facility.

Johnson Matthey PLC (JMAT) · 2026-11-19

Directorate change

Johnson Matthey will replace its COO at year-end under a planned succession process. Richard Pike leaves on 31 December 2026, and Olivier Krotoszyner succeeds him as Group COO on 1 January 2027.

DOTLINES GLOBAL LIMITED (DOTL) · 2026-11-19

Directorate Change

Dotlines Global Limited said Non-executive Director Ashley Paxton will leave the Board on 25 February 2027, creating a planned governance change.

Anglo Asian Mining PLC (AAZ) · 2026-11-19

Return of Gosha and Ordubad Contract Areas

Anglo Asian Mining intends to transfer its non-core Gosha and Ordubad mining rights to the Government of Azerbaijan, subject to Production Sharing Agreement amendments being agreed and approved by the Azerbaijan parliament, while focusing capital and management on copper projects. Gosha rights have expired, Ordubad rights are about to expire, and the company will not seek extensions.

Iomart Group PLC (IOM) · 2026-11-19

COO Appointment to the Board

Iomart has appointed Group COO Craig Mackay to its Board with immediate effect, bringing a senior operational leader into the director group.

Uniphar PLC (UPR) · 2026-11-19

Directorate change

Uniphar has approved Roger Gillespie’s appointment as an independent non-executive director from 25 January 2027, completing the next step in its planned board transition.